Heart failure in patients over 80 years old

La Presse médicale
Emmanuelle BerthelotLuc Hittinger

Abstract

Heart failure (HF) is a clinical syndrome that associates clinical signs in people over 80 years of age, an increase in natriuretic peptides and abnormal cardiac structures that result from cardiac aging in many cases. The most common symptoms are grouped according to the acronym "EPOF" (shortness of breath, weight gain, edema, fatigue). Over the age of 80, comorbidities must be taken into account. The incidence and prevalence of HF significantly increases with age and makes HF the most common reason for hospitalization for people over 80, and an important health expense. The management of HF, necessarily multidisciplinary with a geriatric evaluation, has improved over time due to effective targeted treatment, but mortality, hospitalization and readmission rates remain high. Therapeutic education and patient follow-up for treatment optimization are needed.

References

Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Aug 1, 1989·Cardiovascular Research·M EghbaliO O Blumenfeld
Feb 20, 1997·The New England Journal of Medicine·UNKNOWN Digitalis Investigation Group
May 12, 2000·Journal of the American College of Cardiology·J S GottdienerR C Boineau
Feb 17, 2001·The American Journal of Cardiology·D W KitzmanUNKNOWN Cardiovascular Health Study Research Group
Jun 2, 2001·The New England Journal of Medicine·M PackerUNKNOWN Carvedilol Prospective Randomized Cumulative Survival Study Group
Sep 15, 2001·Mechanisms of Ageing and Development·M L BurgessH L Hedrick
Jan 5, 2002·The New England Journal of Medicine·J N CohnUNKNOWN Valsartan Heart Failure Trial Investigators
Jan 29, 2002·European Journal of Heart Failure·Christopher T C LienMarion E T McMurdo
Jan 22, 2003·Journal of the American College of Cardiology·Frederick A MasoudiHarlan M Krumholz
Nov 12, 2003·The New England Journal of Medicine·Marc A PfefferUNKNOWN Valsartan in Acute Myocardial Infarction Trial Investigators
Oct 27, 2004·Intensive Care Medicine·Patrick RayUNKNOWN EPIDASA Study Group
Nov 4, 2004·La Presse médicale·Olivier Hanon
Sep 12, 2006·European Heart Journal·John G F ClelandUNKNOWN PEP-CHF Investigators
Nov 9, 2006·JAMA : the Journal of the American Medical Association·Francesca BursiVéronique L Roger
Aug 21, 2007·Journal of the American College of Cardiology·Gregg C FonarowUNKNOWN OPTIMIZE-HF Investigators and Hospitals
Sep 2, 2008·European Journal of Heart Failure·Alan MaiselEugene Braunwald
Nov 13, 2008·The New England Journal of Medicine·Barry M MassieUNKNOWN I-PRESERVE Investigators
Sep 2, 2010·European Journal of Heart Failure·Aldo P MaggioniUNKNOWN Heart Failure Association of ESC (HFA)
Nov 16, 2010·The New England Journal of Medicine·Faiez ZannadUNKNOWN EMPHASIS-HF Study Group
Apr 2, 2011·European Journal of Heart Failure·Luis ManzanoUNKNOWN SENIORS Investigators
Oct 20, 2011·JAMA : the Journal of the American Medical Association·Jersey ChenHarlan M Krumholz
Mar 28, 2012·Circulation Journal : Official Journal of the Japanese Circulation Society·Tohru MasuyamaHiroshi Ito

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Aging

This feed focuses on cellular aging with emphasis on mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Related Papers

Zeitschrift für Krankenpflege. Revue suisse des infirmières
G Favez
Reviews in Cardiovascular Medicine
Dipti Itchhaporia
The South Dakota Journal of Medicine and Pharmacy
R L GRISSOM
© 2022 Meta ULC. All rights reserved